Cargando…
A novel full-human CD22-CAR T cell therapy with potent activity against CD22(low) B-ALL
| Autores principales: | , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8036232/ https://www.ncbi.nlm.nih.gov/pubmed/33839735 http://dx.doi.org/10.1038/s41408-021-00465-9 |
| _version_ | 1783676863643648000 |
|---|---|
| author | Tan, Yue Cai, Haodong Li, Chuo Deng, Biping Song, Weiliang Ling, Zhuojun Hu, Guang Yang, Yongkun Niu, Panpan Meng, Guangrong Cheng, Wei Xu, Jinlong Duan, Jiajia Wang, Zelin Yu, Xinjian Feng, Xiaoming Zhou, Jianfeng Pan, Jing |
| author_facet | Tan, Yue Cai, Haodong Li, Chuo Deng, Biping Song, Weiliang Ling, Zhuojun Hu, Guang Yang, Yongkun Niu, Panpan Meng, Guangrong Cheng, Wei Xu, Jinlong Duan, Jiajia Wang, Zelin Yu, Xinjian Feng, Xiaoming Zhou, Jianfeng Pan, Jing |
| author_sort | Tan, Yue |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8036232 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-80362322021-04-27 A novel full-human CD22-CAR T cell therapy with potent activity against CD22(low) B-ALL Tan, Yue Cai, Haodong Li, Chuo Deng, Biping Song, Weiliang Ling, Zhuojun Hu, Guang Yang, Yongkun Niu, Panpan Meng, Guangrong Cheng, Wei Xu, Jinlong Duan, Jiajia Wang, Zelin Yu, Xinjian Feng, Xiaoming Zhou, Jianfeng Pan, Jing Blood Cancer J Correspondence Nature Publishing Group UK 2021-04-10 /pmc/articles/PMC8036232/ /pubmed/33839735 http://dx.doi.org/10.1038/s41408-021-00465-9 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Correspondence Tan, Yue Cai, Haodong Li, Chuo Deng, Biping Song, Weiliang Ling, Zhuojun Hu, Guang Yang, Yongkun Niu, Panpan Meng, Guangrong Cheng, Wei Xu, Jinlong Duan, Jiajia Wang, Zelin Yu, Xinjian Feng, Xiaoming Zhou, Jianfeng Pan, Jing A novel full-human CD22-CAR T cell therapy with potent activity against CD22(low) B-ALL |
| title | A novel full-human CD22-CAR T cell therapy with potent activity against CD22(low) B-ALL |
| title_full | A novel full-human CD22-CAR T cell therapy with potent activity against CD22(low) B-ALL |
| title_fullStr | A novel full-human CD22-CAR T cell therapy with potent activity against CD22(low) B-ALL |
| title_full_unstemmed | A novel full-human CD22-CAR T cell therapy with potent activity against CD22(low) B-ALL |
| title_short | A novel full-human CD22-CAR T cell therapy with potent activity against CD22(low) B-ALL |
| title_sort | novel full-human cd22-car t cell therapy with potent activity against cd22(low) b-all |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8036232/ https://www.ncbi.nlm.nih.gov/pubmed/33839735 http://dx.doi.org/10.1038/s41408-021-00465-9 |
| work_keys_str_mv | AT tanyue anovelfullhumancd22cartcelltherapywithpotentactivityagainstcd22lowball AT caihaodong anovelfullhumancd22cartcelltherapywithpotentactivityagainstcd22lowball AT lichuo anovelfullhumancd22cartcelltherapywithpotentactivityagainstcd22lowball AT dengbiping anovelfullhumancd22cartcelltherapywithpotentactivityagainstcd22lowball AT songweiliang anovelfullhumancd22cartcelltherapywithpotentactivityagainstcd22lowball AT lingzhuojun anovelfullhumancd22cartcelltherapywithpotentactivityagainstcd22lowball AT huguang anovelfullhumancd22cartcelltherapywithpotentactivityagainstcd22lowball AT yangyongkun anovelfullhumancd22cartcelltherapywithpotentactivityagainstcd22lowball AT niupanpan anovelfullhumancd22cartcelltherapywithpotentactivityagainstcd22lowball AT mengguangrong anovelfullhumancd22cartcelltherapywithpotentactivityagainstcd22lowball AT chengwei anovelfullhumancd22cartcelltherapywithpotentactivityagainstcd22lowball AT xujinlong anovelfullhumancd22cartcelltherapywithpotentactivityagainstcd22lowball AT duanjiajia anovelfullhumancd22cartcelltherapywithpotentactivityagainstcd22lowball AT wangzelin anovelfullhumancd22cartcelltherapywithpotentactivityagainstcd22lowball AT yuxinjian anovelfullhumancd22cartcelltherapywithpotentactivityagainstcd22lowball AT fengxiaoming anovelfullhumancd22cartcelltherapywithpotentactivityagainstcd22lowball AT zhoujianfeng anovelfullhumancd22cartcelltherapywithpotentactivityagainstcd22lowball AT panjing anovelfullhumancd22cartcelltherapywithpotentactivityagainstcd22lowball AT tanyue novelfullhumancd22cartcelltherapywithpotentactivityagainstcd22lowball AT caihaodong novelfullhumancd22cartcelltherapywithpotentactivityagainstcd22lowball AT lichuo novelfullhumancd22cartcelltherapywithpotentactivityagainstcd22lowball AT dengbiping novelfullhumancd22cartcelltherapywithpotentactivityagainstcd22lowball AT songweiliang novelfullhumancd22cartcelltherapywithpotentactivityagainstcd22lowball AT lingzhuojun novelfullhumancd22cartcelltherapywithpotentactivityagainstcd22lowball AT huguang novelfullhumancd22cartcelltherapywithpotentactivityagainstcd22lowball AT yangyongkun novelfullhumancd22cartcelltherapywithpotentactivityagainstcd22lowball AT niupanpan novelfullhumancd22cartcelltherapywithpotentactivityagainstcd22lowball AT mengguangrong novelfullhumancd22cartcelltherapywithpotentactivityagainstcd22lowball AT chengwei novelfullhumancd22cartcelltherapywithpotentactivityagainstcd22lowball AT xujinlong novelfullhumancd22cartcelltherapywithpotentactivityagainstcd22lowball AT duanjiajia novelfullhumancd22cartcelltherapywithpotentactivityagainstcd22lowball AT wangzelin novelfullhumancd22cartcelltherapywithpotentactivityagainstcd22lowball AT yuxinjian novelfullhumancd22cartcelltherapywithpotentactivityagainstcd22lowball AT fengxiaoming novelfullhumancd22cartcelltherapywithpotentactivityagainstcd22lowball AT zhoujianfeng novelfullhumancd22cartcelltherapywithpotentactivityagainstcd22lowball AT panjing novelfullhumancd22cartcelltherapywithpotentactivityagainstcd22lowball |